Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lexiscan vs Dipyridamole Rb-82 PET in CAD
NCT00808314Phase 4Unknown
- Sponsor
- Cardiovascular Imaging Technologies
- Start
- Dec 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of regadenoson in coronary artery disease (CAD), sponsored by Cardiovascular Imaging Technologies. Status: unknown.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00808314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808314.